Catalpol counteracts the pathology in a mouse model of Duchenne muscular dystrophy by inhibiting the TGF-β1/TAK1 signaling pathway
Dengqiu Xu, Lei Zhao, Sijia Li, Xiaofei Huang, Chunjie Li, Lixin Sun, Xihua Li, Luyong Zhang, Zhenzhou Jiang
Topics & Concepts
CatalpolDuchenne muscular dystrophySkeletal muscleMyostatinEndocrinologyMuscular dystrophyDystrophinInternal medicinemdx mouseSarcolemmaMedicineTibialis anterior muscleChemistryPharmacologyPathologyAlternative medicineMuscle Physiology and DisordersExercise and Physiological ResponsesAdipose Tissue and Metabolism